Gastrin-releasing peptide links stressor to cancer progression Xinqiu LiYunfu LvZongfang Li Review 06 February 2010 Pages: 483 - 491
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer Kang-Seo ParkHyun-Kyoung KimKyeong-Man Hong Original Paper 18 September 2009 Pages: 493 - 502
Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer Yu Hong LiHui Yan LuoRui Hua Xu Original Paper 24 September 2009 Pages: 503 - 510
Modified apical dissection of the prostate improves early continence in laparoscopic radical prostatectomy: technique and initial results Xin GaoKe-Bing WangJian-Guang Qiu Original Paper 23 September 2009 Pages: 511 - 516
The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites Minkyu JungHei-Cheul JeungSun Young Rha Original Paper 23 September 2009 Pages: 517 - 526
Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations Kimihide YoshidaYasushi YatabeToyoaki Hida Original Paper 24 September 2009 Pages: 527 - 535
US-guided interstitial chemotherapy using paclitaxel temperature-responsive gel for breast cancer treatment in rat Chen Zhi-kuiLin Li-wuCai Min-xian Original Paper 24 September 2009 Pages: 537 - 545
The similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patients Hye-Ryoun KimMin Soo KangJae Cheol Lee Original Paper 30 September 2009 Pages: 547 - 552
Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma Kentaro SakumaAtsushi KasamatsuKatsuhiro Uzawa Original Paper 27 September 2009 Pages: 553 - 559
Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients Matthew T. HartingKevin P. LallyMartin L. Blakely Original Paper 27 September 2009 Pages: 561 - 570
Loss of GDF-15 abolishes Sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer Teresa A. ZimmersJuan C. GutierrezLeonidas G. Koniaris Original Paper 27 September 2009 Pages: 571 - 576
Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices Sebastian Di CesareAndre NantelMiguel N. Burnier Jr Original Paper 13 October 2009 Pages: 577 - 586
Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues Gongyuan ZhangQiao ZhangWeidong Wu Original Paper 13 October 2009 Pages: 587 - 594
Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH Jin-Cai WuBing-Sheng SunLun-Xiu Qin Original Paper 16 October 2009 Pages: 595 - 601
Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling Chunyan SunMeixia ZhangYihui Deng Original Paper 09 October 2009 Pages: 603 - 610
Procalcitonin as a predictive marker of infections in chemoinduced neutropenia Luisa CarninoSilvia BettetoGiulio Mengozzi Original Paper 30 October 2009 Pages: 611 - 615
Long-term follow-up and a detailed prognostic analysis of patients with oropharyngeal cancer treated with radiotherapy Natsuo TomitaTakeshi KodairaNobukazu Fuwa Original Paper 27 October 2009 Pages: 617 - 623
Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma Zhi-xiang YangDong WangXiao-hui Liu Original Paper 31 October 2009 Pages: 625 - 630
Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women Silvia SterponeValeria MastelloneRenata Cozzi Rapid Communication 06 February 2010 Pages: 631 - 636
Erratum to: Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer Xiao-Chun WangLi-Li TianAi-min Meng Retraction Note 30 January 2010 Pages: 637 - 637